Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple rating scale track ADHD in kids with epilepsy?

NCT ID NCT01482026

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether the ADHD Rating Scale-IV can detect changes in attention problems in children with epilepsy. Researchers followed 173 children aged 6 to 15 who had both epilepsy and ADHD. They compared scores over 12 to 16 weeks in treated versus untreated children to see if the scale was sensitive to change. The goal was to validate this tool for future treatment trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could improve how doctors track attention issues in children with epilepsy, helping design better treatments.
What could go wrong
This is an observational validation study, not a treatment trial. It only tests a measurement tool, so it won't directly improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

173 people

The number who actually took part.

Start date

Nov 2011

Finished

Dec 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 16 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * children aged 6 to 15 years and 11 months; * male or female; * with a diagnosis of ADHD : predominantly inattentive or combined hyperactive-impulsive and inattentive according to the DSM IV criteria; * children who agreed to participate to the protocol and whose legal representatives have clearly expressed their non-opposition to participate. Exclusion Criteria: * Patients below 6 years old or patients older than 16 years; * with a diagnosis of ADHD predominantly hyperactive-impulsive subtype ADHD according to the DSM IV criteria; * mental retardation defined by a score \< 70 at the verbal comprehension index and the perceptual reasoning score of the Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV) * established diagnosis of any psychiatric co-morbidity other than ADHD according to the DSM IV criteria (pervasive developmental disorders including autism, bipolar disorder, psychotic disorder).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyperactivity disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy

Contacts and locations

Locations

  • Cabinet Médical du Dr ISNARD

    Lyon, 69002, France

  • Centre Référent des Epilepsies Rares, Hôpital de Hautepierre

    Strasbourg, 67098, France

  • Institut des Epilepsies de l'Enfant et de l'Adolescent, Hôpital Femme Mère Enfant

    Bron, 69677, France

  • Service d'épileptologie pédiatrique, CHR de Chambéry

    Chambéry, 73011, France

  • Service de Neurologie Fonctionnelle et Epileptologie, Hôpital Neurologique Pierre Wertheimer

    Bron, 69677, France

  • Service de Neurologie Pédiatrique, CHU d'Angers

    Angers, 49033, France

  • Service de Neurologie Pédiatrique, CHU de Tours

    Tours, 37044, France

  • Service de Neurologie Pédiatrique, Hôpital Robert-Debré

    Paris, 75019, France

  • Service de Neurologie Pédiatrique, Hôpital des Enfants

    Toulouse, 31059, France

  • Service de Neurologie pédiatrique, CHU d'Amiens

    Amiens, 80054, France

  • Service de Neurologie pédiatrique, CHU de Besançon

    Besançon, 25030, France

  • Service de Neurologie pédiatrique, Hôpital Neckert-Enfants malades

    Paris, 75743, France

  • Service de Neurologie pédiatrique, Hôpital de la Timone

    Marseille, 13385, France

  • Service de Pédiatrie, Hôpital Sud

    Rennes, 35203, France

  • Unité de Neurologie de l'Enfant et de l'Adolescent, Hôpital Pellegrin

    Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.